Jacobs Levy Equity Management, Inc Glaukos Corp Transaction History

Jacobs Levy Equity Management, Inc

  • $24.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 15, 2022
BUY
$46.84 - $58.49 $1.6 Million - $1.99 Million
34,081 New
34,081 $1.81 Million
Q4 2019

Feb 14, 2020
SELL
$54.18 - $65.64 $737,227 - $893,163
-13,607 Closed
0 $0
Q3 2019

Nov 14, 2019
BUY
$58.58 - $83.91 $333,144 - $477,196
5,687 Added 71.81%
13,607 $851,000
Q2 2019

Aug 13, 2019
BUY
$63.59 - $78.71 $503,632 - $623,383
7,920 New
7,920 $597,000

Others Institutions Holding GKOS

# of Institutions
342
Shares Held
46.8M
Call Options Held
132K
Put Options Held
188K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.45B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Jacobs Levy Equity Management, Inc Portfolio

Follow Jacobs Levy Equity Management, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobs Levy Equity Management, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Jacobs Levy Equity Management, Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email